Access cutting-edge endometrial cancer treatment through this clinical trial at a research site in Greenville. Study-provided care at no cost to qualified participants.
Access endometrial cancer specialists in Greenville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related endometrial cancer treatment provided free
This study will assess the safety and efficacy of increasing doses of narazaciclib (ON 123300) in combination with the standard daily dose (2.5mg) of letrozole in patients with Recurrent Metastatic Low-grade Endometrioid Endometrial Cancer and other Gynecologic Malignancies.
Sponsor: Traws Pharma, Inc.
Check if you qualify for this endometrial cancer clinical trial in Greenville, SC
If you're searching for endometrial cancer treatment options in Greenville, SC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Greenville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced endometrial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.